Supply Chain Safety’s Dual Visions: Pedigree Or Just Serialization
This article was originally published in The Pink Sheet Daily
Executive Summary
As Congress considers how to ensure downstream supply chain security, industry groups are looking at a process to link drugs to their manufacturer. But in a recent communication with the Senate HELP Committee, FDA backs a “comprehensive national track-and-trace system.”
You may also be interested in...
Legislative Outlook: Animal Drug User Fee Could Carry Human Drug Proposals
ADUFA reauthorization may become the vehicle to move track and trace and compounding legislation. Reimbursement changes to mitigate shortages appear less likely.
Sen. Burr Tries To Pull FDASIA Over For Speeding As Senate Sends Bill To White House
The North Carolina Republican spends more than two hours talking about the user fee bill and other issues in an apparent effort to delay a final vote, but the Senate easily passes it.
Track-and-Trace Deal’s Failure Leaves California In Control Of Agenda
Industry groups will continue to search for legislative vehicles to move a national standard that would preempt state laws; near-term, though, manufacturers and distributors must prepare for California pedigree law.